Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. IMD-1-0242
Published by: International Institute for Management Development (IMD)
Originally published in: 2005
Version: 12.09.2005
Length: 9 pages
Data source: Field research

Abstract

This is part of a case series. The Novartis Venture Fund (NVF) is considering investing in a start-up, Genedata, and must take into account the valuation analysis by both the start-up as well as Venture Valuation - an independent boutique organisation that specialises in valuing high growth potential start-ups. NVF uses the Venture Valuation inputs to determine how best to structure the next round of financing for Genedata and the case requires the reader to discuss and analyse pricing, further financing requirements, and exit strategy for the fund.
Location:
Size:
USD100 million revenues
Other setting(s):
July 1999

About

Abstract

This is part of a case series. The Novartis Venture Fund (NVF) is considering investing in a start-up, Genedata, and must take into account the valuation analysis by both the start-up as well as Venture Valuation - an independent boutique organisation that specialises in valuing high growth potential start-ups. NVF uses the Venture Valuation inputs to determine how best to structure the next round of financing for Genedata and the case requires the reader to discuss and analyse pricing, further financing requirements, and exit strategy for the fund.

Settings

Location:
Size:
USD100 million revenues
Other setting(s):
July 1999

Related